News

VEON's Strategic Shift: From Euronext Delisting to Nasdaq Focus

VEON's Strategic Shift: From Euronext Delisting to Nasdaq Focus

VEON Announces Transition from Euronext to Nasdaq Trading

VEON Ltd. (NASDAQ:VEON), a prominent global digital operator, has begun its delisting process from the Euronext Amsterdam exchange. This significant move comes with the intent to consolidate all share trading on the Nasdaq Capital Market, aiming for improved liquidity and efficiency for its investors.

Strategic Advantage of Nasdaq Trading

Kaan Terzioglu, the CEO of VEON, emphasized that this decision aligns perfectly with the company's long-term strategy. Centralizing trading on Nasdaq will streamline reporting and administrative processes, positioning VEON favorably in the market landscape. He noted that this transition signifies a commitment to investor confidence, especially as the company plans to relocate its headquarters to Dubai.

Benefits for Shareholders

To assist existing shareholders on Euronext Amsterdam during this shift, VEON is facilitating the adjustment of their holdings. Shareholders will be able to exchange their shares for American depositary shares (ADSs) on Nasdaq, as the company will cover all related issuance fees if they deposit their shares with The Bank of New York Mellon.

VEON’s Impressive Financial Performance

Alongside the operational transitions, VEON has been demonstrating strong financial health. In the second quarter of 2024, the company reported a 12.1% increase in U.S. dollar revenues year-over-year, underscoring its robust growth trajectory.

Digital Growth and Market Expansion

One of the remarkable aspects of VEON's recent performance is its emphasis on digital revenues, which now contribute 10% to the total revenue—an outcome of strategic digital initiatives and the expansion of its 4G network. The firm’s growth in several key markets, including Ukraine and Pakistan, strengthens its overall position in the industry.

Challenges and Future Outlook

Despite the successes, VEON faced challenges, notably a cyber-attack in Ukraine, which adversely affected revenue and EBITDA. However, the company has already begun stabilizing its operations post-incident. Looking forward, VEON anticipates solid revenue growth between 16% to 18% for the full year of 2024, coupled with EBITDA growth expected to be between 18% to 20%. This proactive stance on financial management is encouraging to investors.

Expert Insights on VEON’s Future

As VEON progresses with its significant shifts in trading platform and operations, insights from financial experts shed light on the company’s prospects. VEON's market capitalization is approximately $2.08 billion, affirming its influential stance within the telecommunications sector.

Profitability and Future Strategies

Recent analyses indicate that VEON remains highly profitable, with a substantial total return for shareholders in the past year. Although the company does not distribute dividends currently, its focus on growth aligns with broader market trends and its strategic positioning aimed at frontier markets.

Frequently Asked Questions

What prompted VEON to delist from Euronext Amsterdam?

VEON's decision to delist is to consolidate trading on Nasdaq, aligning with its long-term strategic goals and enhancing liquidity for investors.

Will shareholders on Euronext have to take action?

No action is required from ADS holders who do not own common shares on Euronext during the delisting process.

How did VEON perform financially in Q2 2024?

In Q2 2024, VEON experienced a revenue increase of 12.1% year-over-year, with Group EBITDA rising by 10.6%.

What are VEON’s growth projections for 2024?

VEON is projecting a revenue growth of 16-18% and EBITDA growth of 18-20% for the full year 2024.

Where is VEON relocating its headquarters?

VEON plans to relocate its headquarters to Dubai, aiming to establish itself as a significant player on the Nasdaq exchange from this strategic location.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ajman Tourism Department Hits Internal Audit Milestone

Updated Category News Views 2

A Nod to Standards in Ajman's Tourism Department Folks, it's not every day you see a government department get this kind of spotlight in the internal audit arena, yet here we are. The Ajman Department of Tourism, Culture and Media has snagged Full Conformance with Internal Audit Quality Standards. That’s not just some random feather in their cap but a signal flare in...

Continue Reading
Full Sail University Bags Billboard Music School Honor

Updated Category News Views 4

Full Sail Scores a Billboard Nod — What's the Big Deal? Alright, Full Sail University just snagged a spot on Billboard Magazine's 2026 Top Music Business Schools list. That's no small fry, folks. This Florida institution has been carving out a niche in the music business education scene with a hands-on learning approach that hits the nail right on the head. The Recipe...

Continue Reading
Aspen Dental Brings Comprehensive Care to Whiteville

Updated Category News Views 4

Bringing Dentistry Closer to Home Now, Whiteville's dental game just got a power-up, with Aspen Dental setting up shop in town. This isn't just another practice popping up—it's a full-on dental hub offering everything from regular cleanings to emergency tooth fixes. And let’s face it, this area's diverse population needs it. The Man Behind the Chair Guess who’s at...

Continue Reading
Protecting Your Family on Halloween: Safety Tips

Updated Category News Views 5

Avoid Turning Halloween Fun Into a Medical Emergency Halloween should be about ghosts and ghouls, not a dreaded detour to the ER. Yet, every year, adults and kids get carried away with costumes, only to find themselves in a real-life horror show courtesy of a slip, a fall, or a carving mishap. The American Academy of Orthopaedic Surgeons (AAOS) is waving the safety flag,...

Continue Reading
Lupin Secures FDA Nod for Key Injectable Drug

Updated Category News Views 2

Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...

Continue Reading
Raken Debuts Change Orders: A Game-Changer for Builds

Updated Category News Views 3

Construction Gets a Streamlined Boost with Raken's New Tool In construction, chaos often partners seamlessly with progress. But Raken is stepping in to shake things up a bit. This isn’t just another run-of-the-mill software update; this is Raken flexing its muscles in the construction tech arena. They’ve rolled out Change Orders, enhancing their project management...

Continue Reading
Hexaware Teams with Anthropic for Game-Changing AI Move

Updated Category News Views 3

A Bold AI Partnership on the Horizon Mutual back-slapping or a deal with authentic grit? Hexaware’s latest tango with Anthropic might just be the jolt enterprises need. Announced under the flickering fluorescent lights of Mumbai, London, and Iselin, Hexaware’s multi-year partnership with Anthropic thrusts Claude, their razor-sharp AI, right into the mix of...

Continue Reading
PrideStaff: 8 Years Strong on Franchise Times Top 400

Updated Category News Views 4

Where PrideStaff Stands in the Franchise Landscape Here's something the staffing world can't ignore: PrideStaff nailed it again, landing among the giants on the Franchise Times Top 400 for the eighth straight year. Sitting at number 217, this ain't just a lucky streak—this is a sustained homerun, my friends. Consistency Is Key, And They're Holding It Consider this...

Continue Reading
Mexico's Beaches Shine in 2026 Best America Rankings

Updated Category News Views 4

Mexican Shores Turning Heads in 2026 This isn’t just another wave in tourism news; it’s a tidal shift towards Mexico’s sizzling beaches claiming some prime spots on the global travel stage. If you’ve got an eye for tourism dynamics, listen up because Mexico’s sun-soaked shores just snagged six spots among the top 20 beaches in the Americas, according to the...

Continue Reading
Teamsters Secure Landmark Deal for SF Parking Workers

Updated Category News Views 4

Major Win for San Francisco's Parking Professionals Parking lots and garages across San Francisco might not be the first places you’d look for labor triumphs, but that’s exactly what almost 1,000 members of Teamsters Local 665 have achieved. Under a newly ratified four-year master contract, these parking pros snagged one of the richest deals the industry has seen. A...

Continue Reading

Top 5 Most Recently Viewed Articles

TG Therapeutics Shares Key Presentation Details for BRIUMVI

Updated Category News Views 65

Upcoming Data Presentations for BRIUMVI TG Therapeutics, Inc. (NASDAQ: TGTX) has unveiled an exciting schedule of data presentations that will take place at the 2024 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual meeting. This event, focused on BRIUMVI (ublituximab-xiiy), aims to provide valuable insights for patients dealing with...

Continue Reading
Chinese Equities Rally as Investors Embrace Opportunities

Updated Category News Views 152

China's stock market was the center of attention as traders reflected on the significant gains following government stimulus measures back in 2024. The CSI 300 index saw its most considerable jump in over a decade, signaling a bullish shift that many were eager to ride. Stephen Jen from Eurizon SLJ Capital pointed out this moment could be just the beginning for investors...

Continue Reading
Aethlon Medical's Hemopurifier® Gears Up for Cancer Trial Launch

Updated Category News Views 70

Aethlon Medical's Hemopurifier® Gets the Green Light for Cancer Trials Aethlon Medical, Inc. (NASDAQ: AEMD), a company focused on developing solutions for difficult medical conditions, has received full ethics approval from the Medanta Institutional Ethics Committee. This approval allows them to proceed with a vital safety, feasibility, and dose-finding study of their...

Continue Reading
EON Resources Inc. Engages in Equity Sales and Executive Compensation

Updated Category News Views 44

EON Resources Inc. Executes Equity Sales and Executive Arrangements EON Resources Inc. (NYSE American: EONR), a prominent player in the crude petroleum and natural gas sector, recently made headlines with a series of notable unregistered equity sales. These transactions were outlined in a Form 8-K filed with the SEC, showcasing the company's proactive approach in managing...

Continue Reading
Haemonetics Announces Important Financial Release Date Soon

Updated Category News Views 101

Haemonetics Sets Date for Upcoming Financial Results Haemonetics Corporation, a leading global medical technology company, has announced that its fourth quarter and fiscal year 2025 results will be published soon. Investors and stakeholders are eagerly anticipating these results, which will offer insights into the company's performance over the past year. As a significant...

Continue Reading